Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar dragonmonkey (81.81) Submitted: 5/23/2008 2:15:52 AM : Outperform Start Price: $8.05 OMPI Score: +44.49

Just bought some, so I thought I should list it here. I believe this is a very attactive price point for a company that should recover well when the economy improves.

Featured Broker Partners


Advertisement